Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver metastases from extremity soft tissue sarcoma.

O Merimsky1, P Terrier, A Stanca

  • 1Department of Medicine, Institut Gustave Roussy, Villejuif, France.

American Journal of Clinical Oncology
|February 20, 1999
PubMed
Summary

Soft tissue sarcoma metastasized to the liver is a poor prognostic indicator. While complete surgical removal of liver tumors offers some benefit, systemic chemotherapy is the primary palliative treatment for most patients with unresectable liver metastases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)": [Ann Oncol 26 (2015) 2168-2173].

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Expression of antibody-drug conjugate targets in soft tissue sarcomas.

ESMO open·2025
Same author

Radiation-associated angiosarcoma of the breast: consider chemotherapy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Enhancing radiotherapy with PARP inhibition in soft-tissue sarcomas: a promising synergy requiring specific attention to normal tissues?

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Author's reply to the Letters to the Editor. Six years duration of adjuvant imatinib in high-risk GIST: more to come.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Area of Science:

  • Oncology
  • Hepatology
  • Surgical Pathology

Background:

  • Liver metastases from soft tissue sarcoma significantly worsen patient prognosis.
  • Complete surgical resection of liver metastases can improve outcomes in select cases.
  • Systemic chemotherapy is the main palliative treatment for unresectable liver metastases.

Observation:

  • Soft tissue sarcoma liver involvement presents a challenge in patient management.
  • Complete resection of liver metastases is not feasible for the majority of patients.
  • Anecdotal cases of long-term survival exist even with unresectable liver disease.

Findings:

  • Liver metastases from soft tissue sarcoma are associated with poor survival.
  • Surgical resection offers survival benefits for a subset of patients.

Related Experiment Videos

  • Systemic chemotherapy is the standard palliative approach for unresectable disease.

    • Implications:

    • Further research into novel therapeutic strategies for unresectable soft tissue sarcoma liver metastases is warranted.
    • Optimizing palliative chemotherapy regimens may improve long-term outcomes.
    • Understanding prognostic factors is crucial for patient management and treatment planning.